<- Go home

Added to YB: 2026-05-12

Pitch date: 2026-05-10

ZTS [bullish]

Zoetis Inc.

-6.64%

current return

Author Info

No bio for this author

Company Info

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Market Cap

$34.7B

Pitch Price

$82.12

Price Target

N/A

Dividend

2.56%

EV/EBITDA

10.04

P/E

13.56

EV/Sales

4.41

Sector

Pharmaceuticals

Category

value

Show full summary:
Adding a new Gem & 2 Things I learned this week - Zoetis Inc.

ZTS: Global animal health leader, 70% companion/30% livestock, 300+ products across 8 species. Wide moat (Morningstar). Down 21% post-Q1 on US companion weakness (-11%), but Intl +10%, livestock +12%. Market growing 8-10% CAGR to $150B by 2032. Now 12x fwd P/E (historic low) vs 26% 5yr ROCE—entering Magic Formula territory. Smith/Fundsmith & Rolfe/Wedgewood both building positions. Adding 1-2% starter.

Read full article (3 min)